Evaluation of acute bis(7)-tacrine treatment on behavioral functions in 17-day-old and 30-day-old mice, with attention to drug toxicity

Pharmacology Biochemistry and Behavior

Volumn 86, Issue 4, 2007, Pages 778-783

  Pan, S Y ^a   Yu, Z L ^b   Dong, H ^a   Lee, N T K ^c   Wang, H ^b   Fong, W F ^b   Han, Y F ^c   Ko, K M ^c  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

^c HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

Author keywords

Acute toxicity; Bis(7) tacrine; Hepatotoxicity; Open field memory; Passive avoidance response; Spontaneous motor activity

Indexed keywords

BIS(7)TACRINE; TACRINE DERIVATIVE; UNCLASSIFIED DRUG;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ARTICLE; COGNITION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENCY; LIVER TOXICITY; MALE; MEMORY CONSOLIDATION; MOTOR ACTIVITY; MOTOR DYSFUNCTION; MOUSE; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL;

AGE FACTORS; ANIMALS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; DRUG EVALUATION, PRECLINICAL; LETHAL DOSE 50; LIVER; MALE; MEMORY; MICE; MICE, INBRED ICR; MOTOR ACTIVITY; NOOTROPIC AGENTS; TACRINE;

MUS;

EID: 34249718973     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2007.03.006     Document Type: Article

References (34)

1. Balduini W., Murphy S.D., and Costa L.G. Developmental changes in muscarinic receptor-stimulated phosphoinositide metabolism in rat brain. J Pharmacol Exp Ther 24 (1987) 421-427
2. Balduini W., Murphy S.D., and Costa L.G. Characterization of cholinergic muscarinic receptor-stimulated phosphoinositide metabolism in brain from immature rats. J Pharmacol Exp Ther 253 (1990) 573-579
3. Braida D., Paladini E., Griffini P., Lamperti M., Maggi A., and Sala M. An inverted U-shaped curve for heptylphysostigmine on radial maze performance in rats: comparison with other cholinesterase inhibitors. Eur J Pharmacol 302 (1996) 13-20
4. Carlier P.R., Han Y.F., Chow E.S., Li G.P., Wang H., Lieu T.X., et al. Evaluation of short-tether bis-THA AChE inhibitors. A further test of the dual binding site hypothesis. Bioorg Med Chem 7 (1999) 351-357
5. Daws L.C., and Overstreet D.H. Ontogeny of muscarinic cholinergic supersensitivity in the Flinders Sensitive Line rat. Pharmacol Biochem Behav 62 (1999) 367-380
6. Davis K.L., Thal L.J., Gamzu E.R., Davis C.S., Woolson R.F., Gracon S.I., et al. A double-blind, placebo controlled multicenter study of tacrine for Alzheimer's disease. N Engl J Med 327 (1992) 1253-1259
7. Farlow M., Gracin S.I., Hershey L.A., Lewis K.W., Sadowsky C.H., and Dolan-Ureno J.A. A controlled trial of tacrine in Alzheimer's disease. JAMA 268 (1992) 2523-2529
8. Fu H., Li W., Lao Y., Luo J., Lee N.T., Kan K.K., et al. Bis(7)-tacrine attenuates beta amyloid-induced neuronal apoptosis by regulating L-type calcium channels. J Neurochem 98 (2006) 1400-1410
9. Giacobini E. Cholinesterase inhibitors for Alzheimer's disease therapy: from tacrine to future applications. Neurochem Int 32 (1998) 413-419
10. Knapp M.J., Knopman D.S., Solomon P.R., Pendlebury W.W., Davis C.S., and Gracon S.I. A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. JAMA 271 (1994) 985-991
11. Li C.Y., Wang H., Xue H., Carlier P.R., Hui K.M., Pang Y.P., et al. Bis(7)-tacrine, a novel dimeric AChE inhibitor, is a potent GABA(A) receptor antagonist. Neuroreport 10 (1999) 795-800
12. Li W., P R., i, Chan H.H., Fu H., Lee N.T., Tsang H.W., et al. Novel dimeric acetylcholinesterase inhibitor bis(7)-tacrine, but not donepezil, prevents glutamate-induced neuronal apoptosis by blocking N-methyl-D-aspartate receptors. J Biol Chem 280 (2005) 18179-18188
13. Li W., Lee N.T., Fu H., Kan K.K., Pang Y.P., Li M., et al. Neuroprotection via inhibition of nitric oxide synthase by bis(7)-tacrine. Neuroreport 17 (2006) 471-474
14. Liu J., Ho W., Lee N.T., Carlier P.R., Pang Y.P., and Han Y.F. Bis(7)-tacrine, a novel acetylcholesterase inhibitor, reverse AF-64A-induced deficits in navigational memory in rats. Neurosci Lett 282 (2000) 165-168
15. Marighetto A., Touzani K., Etchamendy N., Torrea C.C., De Nanteuil G., Guez D., et al. Further evidence for a dissociation between different forms of mnemonic expressions in a mouse model of age-related cognitive decline: effects of tacrine and S 17092, a novel prolyl endopeptidase inhibitor. Learn Mem 7 (2000) 159-169
16. Ou L.Y., Tang X.C., and Cai J.X. Effect of huperzine A on working memory in reserpine- or yohimbine-treated monkeys. Eur J Pharmacol 433 (2001) 151-156
17. Pan S.Y. Circadian effects of scopolamine on memory, exploratory behavior, and muscarinic receptors in mouse brain. Acta Pharmacol Sin 13 (1992) 323-326
18. Pan S.Y. Features of memory on novel situation and avoidance response: evidence from comparisons between open-field behavior and step-through task. Acta Pharmacol Sin 16 (1995) 125-129
19. Pan S.Y., Han Y.F., Carlier P.R., Pang Y.P., Mak D.H.F., Lam B.Y.H., et al. Schisandrin B protects against tacrine- and bis(7)-tacrine-induced hepatotoxicity and enhances cognitive function in mice. Planta Med 68 (2002) 217-220
20. Pan S.Y., Han Y.F., Lu Z.L., Yang R., Dong H., and Ko K.M. Evaluation of acute tacrine treatment on passive-avoidance response, open-field behavior, and toxicity in 17- and 30-day-old mice. Pharmacol Biochem Behav 85 (2006) 50-56
21. Patani G.A., Pany Y.P., and Chien Y.W. A potent and selective tacrine analog-biomembrane permeation and physicochemical characterization. Pharm Dev Technol 10 (2005) 525-538
22. Qizilbash N., Whitehead A., Higgins J., Wilcock G., Schneider L., and Farlow M. Cholinesterase inhibition for Alzheimer disease: a meta-analysis of the tacrine trials. Dementia trialists' collaboration. JAMA 280 (1998) 1777-1782
23. Riekkinen Jr. P., Sirvio J., Riekkinen M., and Riekkinen P. Effects of THA on passive avoidance retention performance of intact, nucleus basalis, frontal cortex and nucleus basalis + frontal cortex-lesioned rats. Pharmacol Biochem Behav 39 (1991) 841-846
24. Sabolek H.R., Bunce J.G., and Chrobak J.J. Intraseptal tacrine can enhance memory in cognitively impaired young rats. Neuroreport 5 (2004) 181-183
25. Salmon L., Montet J.C., Oddoze C., Montet A.M., Portugal H., and Michel B.F. Ursodeoxycholic acid and prevention of tacrine-induced hepatotoxicity: a pilot study. Therapie 56 (2001) 29-34
26. Schildein S., Huston J.P., and Schwarting R.K. Injections of tacrine and scopolamine into the nucleus accumbens: opposing effects of immediate vs delayed posttrial treatment on memory of an open field. Neurobiol Learn Mem 73 (2000) 21-30
27. Schildein S., Huston J.P., and Schwarting R.K. Open field habituation learning is improved by nicotine and attenuated by mecamylamine administered posttrial into the nucleus accumbens. Neurobiol Learn Mem 77 (2002) 277-290
28. Stachlewitz R.F., Arteel G.E., Raleigh J.A., Connor H.D., Mason R.P., and Thurman R.G. Development and characterization of a new model of tacrine-induced hepatotoxicity: Role of the sympathetic nervous system and hypoxia-reoxygenation. J Pharmacol Exp Ther 282 (1997) 1591-1599
29. Van Dam D., Hooge R.D., Staufenbiel M., Van Ginneken C., Van Meir F., and De Deyn P.P. Age-dependent cognitive decline in the APP23 model precedes amyloid deposition. Eur J Neurosci 17 (2003) 388-396
30. Wagstaff A.J., and McTavish D. Tacrine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in Alzheimer's disease. Drugs Aging 4 (1994) 510-540
31. Wang H., Carlier P.R., Ho W.L., Wu D.C., Lee N.T.K., Li C.P.L., et al. Effects of bis(7)-tacrine, a novel anti-Alzheimer's agent, on rat brain AChE. Neuroreport 10 (1999) 789-793
32. Wang H., Carlier P.R., Ho W.L., Lee N.T., Pang Y.P., and Han Y.F. Attenuation of scopolamine-induced deficits in navigational memory performance in rats by bis(7)-tacrine, a novel dimeric AChE inhibitor. Acta Pharmacol Sin 20 (1999) 211-217
33. Watkins P.B., Zimmerman H.J., Knapp M.J., and Gracon SI Lewis K.W. Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease. JAMA 271 (1994) 992-998
34. 3H]hemicholinium-3 binding sites in rat neonate brain. Jpn J Pharmacol 84 (2000) 32-35